home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,092 rows where filing_year = 2011 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: is_termination, received_date (date)

filing_period 4

  • second_quarter 289
  • third_quarter 274
  • first_quarter 268
  • fourth_quarter 261

issue_code 1

  • MED · 1,092 ✖

filing_year 1

  • 2011 · 1,092 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1070551 STRATEGIC APPLICATIONS INTERNATIONAL, LLC 5bea6311-62c7-44a2-a4a6-24de371b8325 Q1 STRATEGIC APPLICATIONS INTERNATIONAL, LLC 295337 LUKE COMMISSION 2011 first_quarter MED Secure funding for current and new programs. Health & Human Services, Dept of (HHS),U.S. Agency for International Development (USAID)     0 0 2011-01-27T12:48:22.740000-05:00
1070777 MICHAEL SAULS 53ec246b-cab8-4783-a4f2-9e3cb461c684 Q1 MICHAEL SAULS 43638 MIT HOLDING INC 2011 first_quarter MED Educating Congress and the regulatory agencies about client's products; seeking EPA registration. Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-03-30T15:17:17.370000-04:00
1070782 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) d49b9607-84e9-4bc2-ba5e-9aa814d6fd07 Q1 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 VIJUK EQUIPMENT, INC. 2011 first_quarter MED all issues related to pharmaceutical labeling   25000   0 0 2011-03-30T15:27:21.263000-04:00
1070833 HOLLAND & KNIGHT LLP 8a4fa854-3472-4070-b678-8d9e60152d34 Q1 HOLLAND & KNIGHT LLP 18466 AABB 2011 first_quarter MED Issues related to blood transfusion; tissue transplantation and other laboratory services; blood safety issues; biovigilance programs at CDC and HHS. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-03-31T12:01:17.820000-04:00
1070843 HOLLAND & KNIGHT LLP 2a5467c0-682e-42ca-934c-76830b9821f9 Q1 HOLLAND & KNIGHT LLP 18466 AMERICAN SOCIETY OF HEMATOLOGY 2011 first_quarter MED Hematology and hematology/oncology public health and research issues; HR 640 Bone Marrow Failure Disease Research and Treatment Act of 2011. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2011-03-31T12:10:22.433000-04:00
1070851 HOLLAND & KNIGHT LLP c6b1bb39-0052-4adf-937a-7634680fc959 Q1 HOLLAND & KNIGHT LLP 18466 NATIONAL HEMOPHILIA FOUNDATION 2011 first_quarter MED Biomedical Research; CDC Hemophilia program; HRSA Hemophilia Program Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 40000   0 0 2011-03-31T12:14:25.840000-04:00
1071028 MARSHALL BRACHMAN 4e514a4f-7499-4cce-9318-dd8aef615136 Q1 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2011 first_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2011-04-03T22:24:54.053000-04:00
1071040 MARSHALL BRACHMAN 9595cc09-066b-473a-bf6c-1035c5c5250d Q1 MARSHALL BRACHMAN 6848 ST VINCENT MEDICAL GROUP FORMERLY KNOWS AS THE CARE GROUP LLC 2011 first_quarter MED oppose cuts to diagnostic imaging in any legislative vehicles;reverse outpatient cardiac catheterization practice expense cuts; support accreditation model for diagnostic imaging in HR 3200 and equivalent Senate legislation; support HR 4173 to reverse cuts in 2010 PFS rule HOUSE OF REPRESENTATIVES,SENATE 9000   0 0 2011-04-03T22:36:57.297000-04:00
1071043 MARSHALL BRACHMAN d34b8b90-7d76-4c84-a14f-6aae378a6a9b Q1 MARSHALL BRACHMAN 6848 CARDIOVASCULAR OUTPATIENT CENTER ALLIANCE 2011 first_quarter MED support HR 1293/S. 1338 equivalent in 111th Congress reverse cardiac catheterization practice expense cuts HOUSE OF REPRESENTATIVES,SENATE 12000   0 0 2011-04-03T22:39:58.263000-04:00
1071201 BOB MOSS ASSOCIATES b3019e8b-6aba-4a6f-8f43-290e1e1405e8 Q1 BOB MOSS ASSOCIATES 51877 BURNHAM INSTITUTE FOR MEDICAL RESEARCH (NOW STANFORD-BURNHAM MEDICAL RESEARCH) 2011 first_quarter MED Securing continued support for Sanford Burnham's medical research from Congress. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2011-04-04T17:07:10.533000-04:00
1071476 WAKE FOREST UNIVERSITY HEALTH SCIENCES 97cbd3a8-89c0-4126-b6a7-852aa956f1d5 Q1 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2011 first_quarter MED NIH Budget including Title VII & VIII programs VA-Outpatient Clinic in N.C.(RFP-land acquisition) Great Ape Protection Act (H.R.1326) Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT),Veterans Affairs, Dept of (VA)   160000 0 0 2011-04-06T11:13:33.243000-04:00
1071565 HOLLAND & KNIGHT LLP 68e8c93f-5eed-443a-8a64-2c1994d86d3e Q1 HOLLAND & KNIGHT LLP 18466 SHIRE PHARMACEUTICALS, INC 2011 first_quarter MED Advocate creation and funding of programs to support R&D for rare disease products, biosimilars and other products. Participate in FDA stakeholder meetings re Prescription Drug User Fee program. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-04-06T12:42:13.967000-04:00
1071578 HOLLAND & KNIGHT LLP 1f577934-986d-4181-8f9f-9bec69e207df Q1 HOLLAND & KNIGHT LLP 18466 ALLIANCE FOR REGENERATIVE MEDICINE 2011 first_quarter MED Advocate for funding for regenerative medicine companies and researchers in universities; Advocate for NIH funding for regenerative medicine research. Advocate for funding for the FDA. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE 80000   0 0 2011-04-06T12:52:20.593000-04:00
1071680 AMERICAN COLLEGE OF CLINICAL PHARMACY 9e2450c9-3ed9-4a74-93a0-f2f3fe0e47ea Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2011 first_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   59600 0 0 2011-04-06T15:37:20.920000-04:00
1071886 THE HARRIS FIRM 364dbe15-ab00-4856-8085-3b2a8ea21547 Q1 THE HARRIS FIRM 68376 DIRECT MESSAGE LAB 2011 first_quarter MED Regarding funding for FY 11 pertaining to software communication system for chronic disease management Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-04-07T13:55:12.900000-04:00
1072019 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 210d98a6-503c-41e1-9f05-6bfc6e3963c1 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 COOLEY'S ANEMIA FOUNDATION 2011 first_quarter MED Drug review and approval process Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-07T16:50:50.947000-04:00
1072078 PARRY, ROMANI, DECONCINI & SYMMS f4523e4b-c19d-477b-aa53-968b53875c09 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 AIDS HEALTHCARE FOUNDATION 2011 first_quarter MED Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011 - Support funding for medical treatment for HIV positive patients. Support additional funding for the ADAP program. Continue appropriate funding levels for Chronic Care Special Needs clinics under Medicare. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-08T10:53:25.470000-04:00
1072177 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e1171f7b-dfb0-4170-ba1e-925458678309 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 STATE UNIVERSITY SYSTEM OF FLORIDA 2011 first_quarter MED Appropriations and Authorization legislation for FY 2012 in health care Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE 70000   0 0 2011-04-08T12:18:12.173000-04:00
1072275 DALRYMPLE & ASSOCIATES, LLC e0ba5a4a-6f6f-4f53-a815-187a74d0195b Q1 DALRYMPLE & ASSOCIATES, LLC 5073 SANOFI PASTEUR 2011 first_quarter MED Vaccine research and development legislation, funding, appropriations and oversight. Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office 46000   0 0 2011-04-08T15:07:05.423000-04:00
1072280 DALRYMPLE & ASSOCIATES, LLC db0fd326-6593-449e-9d26-a08ad77d30c6 Q1 DALRYMPLE & ASSOCIATES, LLC 5073 EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) 2011 first_quarter MED Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 46000   0 0 2011-04-08T15:09:08.800000-04:00
1072326 PARRY, ROMANI, DECONCINI & SYMMS 1d5e90af-22f6-4352-8142-09cbad6a0fa9 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2011 first_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-04-08T15:22:26.917000-04:00
1072370 PARRY, ROMANI, DECONCINI & SYMMS ea00aa64-6bd2-400b-bbc9-3978c2947303 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2011 first_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2011-04-08T15:42:43.937000-04:00
1072517 THE PETRIZZO GROUP, INC. e429a30a-7a4d-40c8-9edf-740b509b9b7f Q1 THE PETRIZZO GROUP, INC. 305932 FATE THERAPEUTICS, INC. 2011 first_quarter MED Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health. Defense Advanced Research Projects Agency (DARPA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-10T11:14:15.143000-04:00
1072524 THE PETRIZZO GROUP, INC. 4c392508-9ae4-4a80-a19d-b89b0a41ca87 Q1 THE PETRIZZO GROUP, INC. 305932 SEATTLE BIOMEDICAL RESEARCH INSTITUTE 2011 first_quarter MED Advocate for funding to support next - generation drug development for Leishmaniasis. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-10T11:24:17.257000-04:00
1073010 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) ed66ca43-7617-4cdf-bc38-11259b6ed0b0 Q1 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2970 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2011 first_quarter MED NONE Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE   120000 0 0 2011-04-11T16:18:02.857000-04:00
1073073 PARRY, ROMANI, DECONCINI & SYMMS ad6c9940-589e-4b04-bf56-340f4b6859e3 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2011 first_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-04-11T17:00:42.850000-04:00
1073089 PARRY, ROMANI, DECONCINI & SYMMS 4e1ae626-592c-4b9b-a1c8-114ed5a5372d Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2011 first_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11508   0 0 2011-04-11T17:13:52.467000-04:00
1073103 PARRY, ROMANI, DECONCINI & SYMMS b5c58240-d691-49bb-aced-f39da99456b5 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2011 first_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-04-11T17:24:59.107000-04:00
1073386 WHITMER & WORRALL, LLC 6feb4af9-dc89-40ee-b143-28a1008decbc Q1 WHITMER & WORRALL, LLC 292892 NEURO KINETICS 2011 first_quarter MED Issues related to Traumatic Brain Injury (TBI). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-12T11:09:19.413000-04:00
1073856 BALCH & BINGHAM, LLP 759eb987-72e1-4516-a474-c47454b8be0d Q1 BALCH & BINGHAM, LLP 5197 BIOCRYST PHARMACEUTICALS INC 2011 first_quarter MED Federal response to the pandemic influenza outbreak and pandemic preparedness. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-12T15:41:47.133000-04:00
1073984 POLICY DIRECTIONS INC. 538f145d-1002-4f22-b23d-2f17852d9a84 Q1 POLICY DIRECTIONS INC. 31747 VITAPATH GENETICS, INC. 2011 first_quarter MED New regulatory requirements for diagnostics. Seeking federal funding for novel genetic diagnostic tests. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-12T16:54:56.560000-04:00
1074040 JAMES P. KEESE a2ce4c1a-e752-4765-a7f2-854b65123821 Q1 JAMES P. KEESE 74556 INSTANTLABS MEDICAL DEVICE CORPORATION 2011 first_quarter MED Issues pertaining to the Clinical Laboratory Imporvement Act (42 U.S.C. 263a) S. 510, H R 2751 - The FDA Food Safety Modernization Act, all provisions. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2011-04-12T17:57:31.333000-04:00
1074169 CLARK & WEINSTOCK 53efca80-0f17-493a-a9d6-50da2c8f1e06 1T CLARK & WEINSTOCK 9443 AUSTEN BIOINNOVATION INSTITUTE 2011 first_quarter MED Funding for medical research; health policy. Army, Dept of (Other),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Science & Technology Policy (OSTP),SENATE     0 1 2011-04-13T09:44:45.483000-04:00
1074256 CHARLIE MCBRIDE ASSOCIATES 6fe9eae3-081f-41bf-8b89-e2a8fe8bc515 Q1 CHARLIE MCBRIDE ASSOCIATES 24214 BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA 2011 first_quarter MED To monitor legislation affecting medical energy research and technology-based economic development HOUSE OF REPRESENTATIVES,SENATE 7200   0 0 2011-04-13T10:53:30.017000-04:00
1074415 STANFORD UNIVERSITY 6d85cdc2-b80f-400d-bd63-1dc5474b698f Q1 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2011 first_quarter MED Stem Cell Research Policy Defense, Dept of (DOD),Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   120000 0 0 2011-04-13T12:26:09.273000-04:00
1074661 THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 33303486-2641-4a53-a1b2-5a4b3f645093 Q1 THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 38585 TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2011 first_quarter MED NIH, GME, Title VII HOUSE OF REPRESENTATIVES,SENATE   11047 0 0 2011-04-13T14:38:32.723000-04:00
1074693 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. bbf22eea-21a5-48ec-b6e4-72c8cd2bb515 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2011 first_quarter MED No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, Tuberous Sclerosis HR 1473, Defense Appropriations Bill, FY 2011, Tuberous Sclerosis Complex Research Program Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2011-04-13T14:49:50.183000-04:00
1074948 LATHAM & WATKINS LLP e444e0cc-e0d1-4974-9672-b250e0ac100a Q1 LATHAM & WATKINS LLP 22201 BOSTON SCIENTIFIC CORPORATION 2011 first_quarter MED Congressional oversight of the Food and Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-13T16:57:13.143000-04:00
1074972 AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES 7b38c1e2-0dbd-4102-a74c-f89748d0f299 Q1 AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES 1524 AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO 2011 first_quarter MED S. 3686, appropriations for the National Heart, Lung and Blood Institute included in the FY 2011 Labor, HHS and Education Appropriations bill HOUSE OF REPRESENTATIVES   23000 0 0 2011-04-13T17:15:35.357000-04:00
1075108 BEN BARNES GROUP LP 54b8855b-ad5e-4617-bf5e-9fc473ec6de3 Q1 BEN BARNES GROUP LP 5415 HUNTSMAN CANCER INSTITUTE 2011 first_quarter MED Medical research HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2011-04-13T18:26:46.750000-04:00
1075511 MCDERMOTT WILL & SCHULTE LLP 3742efae-1c2c-4863-bdb4-a9a3cf36a934 Q1 MCDERMOTT WILL & SCHULTE LLP 24338 ISIS PHARMACEUTICALS 2011 first_quarter MED Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-04-14T11:17:24.677000-04:00
1075543 MCDERMOTT WILL & SCHULTE LLP 5f9dc4b3-e78c-4295-aadf-44fa2d451f3e Q1 MCDERMOTT WILL & SCHULTE LLP 24338 MAYO CLINIC 2011 first_quarter MED Address the safety, health and environmental concerns regarding the transport by railroad of hazardous commodities and coal traffic near the Rochester, Minnesota Mayo Clinic facility; more than 30,000 doctors and staff use this facility each day. The multi-year Surface Transportation Authorization Act and the House THUD Subcommittee 2011 Transportation, Housing and Urban Development Appropriations Bill. HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT) 25000   0 0 2011-04-14T11:25:39.437000-04:00
1075858 GOLDBUG STRATEGIES LLC d18953cc-b8b8-461e-aaea-93e06a4afd8a Q1 GOLDBUG STRATEGIES LLC 400701094 GENOMIC HEALTH INC. 2011 first_quarter MED FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 110000   0 0 2011-04-14T13:45:19.037000-04:00
1075868 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 7c708282-69c1-41e5-9543-fd37f108f305 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION 2011 first_quarter MED No Bill #, Labor/HHS/Education Appropriations Bill, FY 2012, HHT research Continuing Resolutions, FY 2011 No Bill#, HHT Research and Treatment Act Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-14T13:49:24.440000-04:00
1075877 GOLDBUG STRATEGIES LLC a318d775-8802-492f-8959-5f3b2bb26f5d Q1 GOLDBUG STRATEGIES LLC 400701094 GENOMIC HEALTH INC. 2011 first_quarter MED FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 110000   0 0 2011-04-14T13:51:29.940000-04:00
1075901 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9ea241b2-d7c3-4d60-a61a-1ba1de3d3ed6 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION 2011 first_quarter MED No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research No Bill#, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease Bone Marrow Failure Disease Research and Treatment Act Continuing Resolutions, FY 2011 Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2011-04-14T13:56:38.737000-04:00
1075930 GOLDBUG STRATEGIES LLC 8ccd18fd-fba2-4425-9dbd-0e844f716acf Q1 GOLDBUG STRATEGIES LLC 400701094 COALITION FOR 21ST CENTURY MEDICINE 2011 first_quarter MED FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-04-14T14:06:52.323000-04:00
1075984 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 5ffe2a9f-e61a-40fa-a472-91d241e44df8 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 SAGE PUBLICATIONS, INC. 2011 first_quarter MED No Bill#, Federal Research Public Access Act National Institutes of Health Open Access policy No Bill#, America COMPETES Act, implementation of public access policy at federal science agencies No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, NIH Open Access Policy, Department of Education Title II Funding No Bill#, Reauthorization of Elementary and Secondary Education Act, Title II Funding HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-14T14:26:23.737000-04:00
1076054 THE CJR GROUP, INC. c7982d88-3a07-4a19-81bb-c06c36f6846b Q1 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2011 first_quarter MED Medical issues relating to hospitals HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-14T14:54:59.617000-04:00
1076157 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY b5261586-9b04-4b13-83cf-f13a687dbfb8 Q1 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 3435 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 2011 first_quarter MED Appropriations for Federal Health Agencies Elimination of Physician Signature Requirement Under Medicare PFS Stark Self Referral Reform Laboratory Workforce Shortage; Regulation of Laboratory Developed Tests Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),SENATE   50000 0 0 2011-04-14T15:24:01.670000-04:00
1076264 ASSN OF MEDICAL DEVICE REPROCESSORS 356f0db4-eb97-4a83-8306-360e872fcdf7 Q1 ASSN OF MEDICAL DEVICE REPROCESSORS 291732 ASSN OF MEDICAL DEVICE REPROCESSORS 2011 first_quarter MED Educated Congressional staff, members of Congress, and FDA officials on FDA-regulated, third-party reprocessing industry. HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2011-04-14T16:02:08.843000-04:00
1076338 PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE d42355bc-eb3f-472c-a3a3-62dba2c66439 Q1 PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE 400382759 PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE 2011 first_quarter MED Urging members of Congress to introduce and co-sponsor H.R. 1513 and S. 810, the Great Ape Protection and Cost Savings Act, which would phase out invasive research on chimpanzees and retire chimpanzees owned by the federal government to permanent sanctuaries. Urging members of Congress to introduce and support legislation to encourage the government to promote medical simulation technologies. HOUSE OF REPRESENTATIVES,SENATE   11805 0 0 2011-04-14T16:45:54.700000-04:00
1076354 FAEGRE DRINKER BIDDLE & REATH LLP ec4007f0-1186-4989-8fe0-74039b017a92 Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PREECLAMPSIA FOUNDATION 2011 first_quarter MED Preeclampsia Research HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH) 10000   0 0 2011-04-14T16:54:05.493000-04:00
1076366 FAEGRE DRINKER BIDDLE & REATH LLP f051891f-8c2b-40a9-bca2-4b621b01cc7e Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 SPINA BIFIDA ASSOCIATION 2011 first_quarter MED Spina Bifida Research and Awareness and Access to Care; Medical Device User Fee Act. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 40000   0 0 2011-04-14T17:01:14.067000-04:00
1076401 FAEGRE DRINKER BIDDLE & REATH LLP c6f4d0fb-a2f0-4b3b-85ba-a287226fe592 Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PREVENT BLINDNESS 2011 first_quarter MED Eye Disease and Vision Health; Treatment and Prevention of Blindness and Vision Loss. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2011-04-14T17:18:34.593000-04:00
1076424 CORNERSTONE GOVERNMENT AFFAIRS, INC. acfabf04-836d-4160-9788-a6f53896cd1b Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 PATH 2011 first_quarter MED Monitor issues related to global health and technology. Track USG activity and expenditures on medical research and development. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-14T17:29:47.633000-04:00
1076463 FAEGRE DRINKER BIDDLE & REATH LLP 400dd994-3c56-4316-9a32-86a4131d3f94 Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 RIVERAIN MEDICAL 2011 first_quarter MED Increasing awareness of lung cancer and making it a public health priority Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-14T17:41:03.583000-04:00
1076479 FAEGRE DRINKER BIDDLE & REATH LLP 8fee103e-46ba-4421-8028-d0289a26a14f Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA 2011 first_quarter MED Public Health and Medical Research Programs for Neglected and Infectious Diseases; H.R. 528 - Neglected Infections of Impoverished Americans Act. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-14T17:45:12.143000-04:00
1076486 FAEGRE DRINKER BIDDLE & REATH LLP 9b429ee2-02ac-4c3c-ba2c-0ebfbe9a05e1 Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 OVARIAN CANCER NATIONAL ALLIANCE 2011 first_quarter MED Ovarian Cancer Research and Awareness; Implementation of Johanna's Law. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-14T17:48:15.907000-04:00
1076498 FAEGRE DRINKER BIDDLE & REATH LLP 779f02c3-e2be-4490-abe8-4893725aa88a Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2011 first_quarter MED Public Health Programs for Infectious and Tropical Disease; Issues related to Neglected Disease Product Approval; S. 641 - Water for the World Act of 2009; H.R. 528 - Neglected Infections of Impoverished Americans Act; CDC Infection and Vector Borne Disease Programs. Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID) 30000   0 0 2011-04-14T17:53:22.087000-04:00
1076509 THREE BRIDGES ADVISORS, INC. 3ca72f85-a858-4abb-b3dc-0853caedde83 Q1 THREE BRIDGES ADVISORS, INC. 400689049 VAN SCOYOC ASSOCIATES (MT. DESERT ISLAND BIOLOGICAL LABORATORY (MDIBL)) 2011 first_quarter MED Biomedical research funding for regenerative medicine program. HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 10000   0 0 2011-04-14T17:58:28.040000-04:00
1076738 DALRYMPLE & ASSOCIATES, LLC 9a9d9def-b2ed-4952-8fe3-473abbac0430 Q1 DALRYMPLE & ASSOCIATES, LLC 5073 BRIGHTON BIOTECH, INC. 2011 first_quarter MED Biodefense small molecule medical countermeasure against CBRN threats and orphan drug research and development funding, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 10000   0 0 2011-04-15T10:21:37.853000-04:00
1076774 MCDERMOTT WILL & SCHULTE LLP 71b10400-869b-4876-adb1-9d83a204c2df Q1 MCDERMOTT WILL & SCHULTE LLP 24338 COALITION FOR 21ST CENTURY MEDICINE 2011 first_quarter MED Issues concerning regulation of laboratory tests. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2011-04-15T10:34:58.863000-04:00
1076789 MCDERMOTT WILL & SCHULTE LLP 1bce3360-ec0b-4d67-be30-eb15307652a5 Q1 MCDERMOTT WILL & SCHULTE LLP 24338 GENOMIC HEALTH INC 2011 first_quarter MED FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2011-04-15T10:41:06.173000-04:00
1076907 LIFE TECHNOLOGIES CORPORATION 8b172da9-025e-4f87-9d31-11c639dc34eb Q1 LIFE TECHNOLOGIES CORPORATION 400391833 LIFE TECHNOLOGIES CORPORATION 2011 first_quarter MED BETTER Care Act (No Bill number to date); Provisions regarding lab developed tests. HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2011-04-15T11:30:18.263000-04:00
1077004 MAYO CLINIC 013ac45b-d118-47eb-bf49-fc8ea4b943e9 Q1 MAYO CLINIC 400270238 MAYO CLINIC 2011 first_quarter MED Lab payment issues Research funding HOUSE OF REPRESENTATIVES,SENATE   210000 0 0 2011-04-15T12:13:24.613000-04:00
1077020 WEBMD HEALTH CORP. 57a1efb3-6eb4-40e3-864e-b16b41bb0b72 Q1 WEBMD HEALTH CORP. 55473 WEBMD HEALTH CORP 2011 first_quarter MED Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and the deduction of expenses associated with advertising; Personal health records. SENATE   30000 0 0 2011-04-15T12:20:38.193000-04:00
1077335 FAEGRE DRINKER BIDDLE & REATH LLP 0d3eccca-dcab-44b3-97e5-5bc9dc3d8350 Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 NATIONAL PSORIASIS FOUNDATION 2011 first_quarter MED Pending reintroduction of the Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act; Psoriasis Data Collection. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 60000   0 0 2011-04-15T14:24:50.203000-04:00
1077344 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 738fa514-c5ae-4bb0-984a-049b2c789679 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ONYX PHARMACEUTICALS 2011 first_quarter MED Innovation in biotechnology; biosimilars; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-15T14:28:54.157000-04:00
1077399 HEALTHFUTURES, LLC 68bec15f-6f40-423b-8f0b-2e9c4a8256a2 Q1 HEALTHFUTURES, LLC 400359646 ASSOCIATION FOR MOLECULAR PATHOLOGY 2011 first_quarter MED Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics No Bill#, Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act No Bill#, BETTER Patient Care Act Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE 30000   0 0 2011-04-15T14:43:22.837000-04:00
1078334 BROWNSTEIN HYATT FARBER SCHRECK, LLP 19d97675-1162-4961-9e89-023500c0217d Q1 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 MOBILE MEDICAL INTERNATIONAL CORPORATION 2011 first_quarter MED Develop partnership with Veterans Administration (VA) to provide mobile surgery units (MSUs) throughout system when VA operating rooms are under construction or renovation, or additional capacity is needed soon, thus saving the VA money and other benefits. SENATE,Veterans Affairs, Dept of (VA) 50000   0 0 2011-04-15T22:12:37.790000-04:00
1078421 CAPITOL CONSULTING GROUP, LLC b81fd35b-65d4-4ebd-883c-8ed6bf59b60d Q1 CAPITOL CONSULTING GROUP, LLC 400366700 LIFECELL CORPORATION 2011 first_quarter MED FY11 and 12 defense appropriations bill, Army medical research and development programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-16T11:52:36.997000-04:00
1078463 BEN BARNES GROUP LP 9620541d-b28a-4336-a701-adf54ae8c66c Q1 BEN BARNES GROUP LP 5415 OKLAHOMA RESEARCH MEDICAL FOUNDATION 2011 first_quarter MED Medical research SENATE 20100   0 0 2011-04-16T15:20:02.190000-04:00
1078494 DUKE UNIVERSITY ba1c1a3e-d9fc-49a9-917f-dbb6aed3dab7 Q1 DUKE UNIVERSITY 314294 DUKE UNIVERSITY 2011 first_quarter MED Medical, Disease Research, and Clinical Lab Issues Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS)   98001 0 0 2011-04-17T12:06:41.840000-04:00
1078585 PERSONALIZED MEDICINE COALITION 307b1d74-ecc0-44c9-8952-91e9160b1dc8 Q1 PERSONALIZED MEDICINE COALITION 40046362 PERSONALIZED MEDICINE COALITION 2011 first_quarter MED CER, CMS, Coverage of Genetic Testing Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   6416 0 0 2011-04-17T17:51:39.517000-04:00
1078635 THE PETRIZZO GROUP, INC. f5fe53fc-936d-4d5d-a061-f1298b540e28 Q1 THE PETRIZZO GROUP, INC. 305932 FRED HUTCHINSON CANCER RESEARCH CENTER 2011 first_quarter MED Advocated for level funding for the National Institutes of Health and National Cancer Institute for FY 2011 federal funding. Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-17T21:36:13.060000-04:00
1078644 DANIELLE ORGAN PETERS d53c11f9-4b19-417b-a9ba-5dfbd5fb75e8 Q1 DANIELLE ORGAN PETERS 400427062 FABIANI & COMPANY ON BEHALF OF MEDRAD INC. 2011 first_quarter MED Cell therapy delivery research Natl Aeronautics & Space Administration (NASA),Natl Institutes of Health (NIH)     0 0 2011-04-17T22:03:18.513000-04:00
1078770 SQUIRE PATTON BOGGS dd1a8f62-241c-4b38-a70b-8a2474e89bed Q1 SQUIRE PATTON BOGGS 30906 MELA SCIENCES, INC. 2011 first_quarter MED FDA regulatory procedures with respect to melanoma detection systems. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2011-04-18T08:12:38.147000-04:00
1078787 THE PETRIZZO GROUP, INC. 99c66a40-b2d1-4215-a7ec-cc0f98fbd274 Q1 THE PETRIZZO GROUP, INC. 305932 SEATTLE CANCER CARE ALLIANCE 2011 first_quarter MED Advocate for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs. Support introduction and passage of The Cancer Center Assistance for Renovation and Expansion Act, H.R. 5861. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-18T08:19:50.240000-04:00
1078816 NELSON MULLINS RILEY & SCARBOROUGH 17a67c88-6fbe-49bf-ba5b-16acd9cb8648 Q1 NELSON MULLINS RILEY & SCARBOROUGH 285871 SOCIETY OF BEHAVIORAL MEDICINE 2011 first_quarter MED NIH budget; health care prevention and wellness programs HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-18T08:29:10.707000-04:00
1078829 THE PETRIZZO GROUP, INC. fb4c8820-9048-4914-9925-bc7436bb31a1 Q1 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2011 first_quarter MED Advocate for federal funding for GAPPS Project -- Understanding Increased Risk of Preterm Birth and Stillbirth in a Post-Combat Setting. This request is aimed at improving our understanding of factors which contribute to preterm and stillbirths around the world. Specifically, federal funding would examine how and whether poor nutrition, impoverishment, the high stress of living in war-torn areas, and exposure to various toxins and pathogens increase rates of preterm birth and stillbirth rates. This project will provide the U.S. Army with research that will inspire new diagnostics, therapeutics and other innovations to improve birth outcomes and prevent prematurity and stillbirths. This research will extrapolate to a broader range of maternal health conditions as they relate to the priorities of the Department of Defense for warfighter health. Advocated for legislativion to create pediatric research hubs to maximize the impact of existing pediatric research capacity and boost funding for research benefitting children. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-18T08:43:17.513000-04:00
1078944 POLICY DIRECTIONS INC. 4539925a-8688-4f84-a7fc-3d9c4cacfd87 Q1 POLICY DIRECTIONS INC. 31747 ADVANCED LIFE SCIENCES 2011 first_quarter MED FDA regulatory pathway for new antibiotic medicines. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-18T09:41:21.843000-04:00
1078982 HEALTHFUTURES, LLC bfc5fe10-2586-4481-a1f5-8f0e2a32ba3c Q1 HEALTHFUTURES, LLC 400359646 NAVIGENICS, INC. 2011 first_quarter MED Oversight and regulation of genetic testing Direct to consumer genetic testing Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-18T09:45:36.343000-04:00
1079030 HEALTHFUTURES, LLC e9310c28-9d9d-41c1-bba0-023b97adb04d Q1 HEALTHFUTURES, LLC 400359646 LIFE TECHNOLOGIES 2011 first_quarter MED No Bill#, Genomics and Personalized Medicine Act, Personalized medicine Health information technology Regulation and reimbursement of laboratory-developed tests No Bill#, BETTER Patient Care Act Whole genome sequencing Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2011-04-18T09:56:03.483000-04:00
1079061 THE PETRIZZO GROUP, INC. 1866872b-575a-4491-ae80-556ee2f2a1a2 Q1 THE PETRIZZO GROUP, INC. 305932 SAGE THERAPEUTICS, INC. 2011 first_quarter MED Advocated for federal funding to support development of neuroactive steroids to yield therapeutics with a core focus on Traumatic Brain Injury (TBI), Post-Traumatic Stress Disorder (PTSD), and Pain. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-18T10:01:20.237000-04:00
1079180 KSCW, INC. 85a6ffdd-49f4-4df6-a683-2b4a59a327b6 Q1 KSCW, INC. 21596 INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS (IAMERS 2011 first_quarter MED Legislation and regulation affecting the Medical device industry HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-18T10:18:28.520000-04:00
1079289 KSCW, INC. e831f94c-484a-4d93-ad7a-3e31698bf9ac Q1 KSCW, INC. 21596 MCBRIDE MEDICAL GROUP, INC. 2011 first_quarter MED Physician Reimbursement, Innovative Delivery Systems HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-18T10:31:22.543000-04:00
1079394 ALPINE GROUP PARTNERS, LLC. 5d9ae768-f676-4df2-a1ac-8a3907cfe9ac Q1 ALPINE GROUP PARTNERS, LLC. 1171 AMERICAN COLLEGE OF RADIOLOGY 2011 first_quarter MED reauthorization of Mamography Quality Standards Act (MQSA) HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-04-18T10:47:17.937000-04:00
1079424 FEDERAL SOLUTIONS, LLC e68fd23e-bb62-4c54-ac00-41c3c983f651 Q1 FEDERAL SOLUTIONS, LLC 311371 JACKSONVILLE STATE UNIVERSITY 2011 first_quarter MED Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research, education, and development. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-18T10:53:41-04:00
1079468 FEDERAL SOLUTIONS, LLC 377f6032-55c0-45c3-92e2-9e88f3f02bbf Q1 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2011 first_quarter MED Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Aeronautics & Space Administration (NASA),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2011-04-18T10:58:57.503000-04:00
1080986 DENNY MILLER ASSOCIATES 4599b31d-b338-4124-9ea2-353d29145ac5 Q1 DENNY MILLER ASSOCIATES 25328 ST PATRICK HOSPITAL AND HEALTH SCIENCE CENTER 2011 first_quarter MED Implementation of Patient Protection and Affordable Care Act (Public Law III - 148), provisions relating to the Center for Medicare and Medicaid Innovation grant program. Federal funding/grant opportunities in the Dept of Health and Human Services. Implementation of the Department of Defense Appropriations Act, 2010 (Public Law 111-118), Title IV, provisions relating to US Army medical research. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-18T14:49:56.170000-04:00
1081102 DENNY MILLER ASSOCIATES c6ab2e35-1072-4af9-b35b-6516b3ffaa47 Q1 DENNY MILLER ASSOCIATES 25328 SABEY CORPORATION 2011 first_quarter MED Oversight and implementation of the Patient Protection and Affordable Care Act (Public Law 111-148), provisions relating to the Center for Medicare and Medicaid Innovation grant program. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-18T15:03:03.310000-04:00
1081256 PARALYZED VETERANS OF AMERICA b4f187a4-6e09-4678-8ef4-6f00c24d6f59 Q1 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2011 first_quarter MED Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   84657 0 0 2011-04-18T15:17:20.403000-04:00
1081941 MARSHFIELD CLINIC HEALTH SYSTEM 7a581052-325b-48b2-87d6-0dfe6930f376 Q1 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2011 first_quarter MED The Centers for Medicare and Medicaid Services (CMS) required in the 2011 Medicare Physician Fee Schedule Final Rule that laboratory requisition forms be signed by the ordering physician. We asked that CMS consider delaying enforcement of the requirement, possibly for an additional nine months. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE   130000 0 0 2011-04-18T17:00:40.887000-04:00
1082194 BROWNSTEIN HYATT FARBER SCHRECK, LLP 6f17878b-3030-44f1-a917-315f71511c26 Q1 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 VIVUS, INC. 2011 first_quarter MED FDA approval process HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2011-04-18T17:35:49.417000-04:00
1082532 BROWNSTEIN HYATT FARBER SCHRECK, LLP b60a8552-56e3-4b86-9d9a-000ac469ae0f Q1 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 ZOLL DATA SYSTEMS 2011 first_quarter MED Issues relating to healthcare IT funding Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-18T19:40:30.367000-04:00
1082617 BROWNSTEIN HYATT FARBER SCHRECK, LLP c920bfd3-a6c1-43af-ab39-57ef17c0068e Q1 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 ABBOTT LABORATORIES 2011 first_quarter MED Healthcare reform Legal reform Theft of medical products   20000   0 0 2011-04-18T21:06:10.910000-04:00
1082795 VAN SCOYOC ASSOCIATES 2bc0e67f-55bc-4f56-aa53-00818a25a694 Q1 VAN SCOYOC ASSOCIATES 39837 MEDICINES FOR MALARIA VENTURE 2011 first_quarter MED USAID and Malaria research and development issues and initiatives Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID) 30000   0 0 2011-04-19T06:18:35.340000-04:00
1082804 VAN SCOYOC ASSOCIATES 40489966-4c3c-442a-a7ee-a93981623291 Q1 VAN SCOYOC ASSOCIATES 39837 CUREMARK LLC 2011 first_quarter MED Therapeutic treatment for autism issues generally. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2011-04-19T06:23:38.807000-04:00
1083426 AMERICAN SOCIETY OF HEMATOLOGY 87447146-af02-4b0c-ba38-f4b25b567de3 Q1 AMERICAN SOCIETY OF HEMATOLOGY 59171 AMERICAN SOCIETY OF HEMATOLOGY 2011 first_quarter MED H.R. 640, the Bone Marrow Failure Disease Research and Treatment Act General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues Embryonic Stem Cell Research and Regenerative Medicine Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research S. 296, the Preserving Access to Life-Saving Medications Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Nuclear Regulatory Commission (NRC),SENATE   30000 0 0 2011-04-19T09:26:33.130000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1519.755ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API